Seeking Alpha
All posts from Seeking Alpha
Seeking Alpha in Seeking Alpha - Read, Decide, Invest.,

Arena's Belviq Sales Need Better Pace

Sales of Arena's (NASDAQ:ARNA) Belviq saw the most impressive week over week comparisons of the new anti-obesity drugs this week, but remain shy of the pace needed to deliver the type of revenue that analysts, the Street, and savvy investors are seeking. Simply stated, a caution flag on Belviq sales remains steadfastly in place. Belviq sales closed out the week at a bit above 11,800 according to tracking service IMS health. The 3.5% gain is in positive territory but acceleration is not enough to hit the outlined pace needed in order to achieve $35 million in sales revenue for…